Synergy of Microfluidics and Nanomaterials: A Revolutionary Approach for Cancer Management
ACS Applied Bio Materials · 2025
DOI: 10.1021/acsabm.5c00123 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Applied Bio Materials, 2025. Verfasst von Pramoda G und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)-Raebareli, Lucknow, Uttar Pradesh 226002, India. Hauptthemen laut MEDLINE: Neoplasms, Microfluidics, Antineoplastic Agents, Biocompatible Materials. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 184 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)-Raebareli, Lucknow, Uttar Pradesh 226002, India.
- Centre for Development of Biomaterials and Department of Life Sciences, Sharda School of Bio-Science and Technology, Sharda University, Greater Noida, Uttar Pradesh 201310, India.
- Centre for Research Impact & Outcome, Chitkara University Institute of Engineering and Technology, Chitkara University, Rajpura, Punjab 140401, India.
ORCID-Profile: Piyush Kumar Gupta, Rahul Shukla
Zitieren
APA
G, P., Singh, M., Gupta, P. K., & Shukla, R. (2025). Synergy of Microfluidics and Nanomaterials: A Revolutionary Approach for Cancer Management. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.5c00123
Vancouver
G P, Singh M, Gupta PK, Shukla R. Synergy of Microfluidics and Nanomaterials: A Revolutionary Approach for Cancer Management. ACS Applied Bio Materials. 2025. doi:10.1021/acsabm.5c00123
BibTeX
@article{G2025,
author = {G, Pramoda and Singh, Mansi and Gupta, Piyush Kumar and Shukla, Rahul},
title = {Synergy of Microfluidics and Nanomaterials: A Revolutionary Approach for Cancer Management},
journal = {ACS Applied Bio Materials},
year = {2025},
doi = {10.1021/acsabm.5c00123}
}
EUVIMED